<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study examines the suitability of the intracranial route of transplantation of human cell lines in <z:mp ids='MP_0003815'>nude</z:mp> mice for preclinical testing of <z:chebi fb="0" ids="35610">cytostatic</z:chebi> drugs </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumours</z:e> were generated by inoculation of human hematopoietic cell lines </plain></SENT>
<SENT sid="2" pm="."><plain>Animals in which intramuscularly or intracranially transplanted human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> developed were treated with <z:chebi fb="0" ids="35610">cytostatic</z:chebi> drugs </plain></SENT>
<SENT sid="3" pm="."><plain>Three different cell line generated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> L735, Hodgkin cell line L540 and Burkitt <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> Line BJAB) were treated with four different drugs (CY, ADM, VCR, <z:chebi fb="0" ids="4911">VP16</z:chebi>) </plain></SENT>
<SENT sid="4" pm="."><plain>The data show a good correspondence between the results of treatment of intramuscularly and intracranially transplanted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Thus intracranially transplanted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice are suitable for the testing of <z:chebi fb="0" ids="35610">cytostatic</z:chebi> drugs </plain></SENT>
</text></document>